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Background: Many prognostic models have been developed. Different types of models, i.e. prognostic factor and
outcome prediction studies, serve different purposes, which should be reflected in how the results are summarized
in reviews. Therefore we set out to investigate how authors of reviews synthesize and report the results of primary
outcome prediction studies.
Methods: Outcome prediction reviews published in MEDLINE between October 2005 and March 2011 were eligible
and 127 Systematic reviews with the aim to summarize outcome prediction studies written in English were
identified for inclusion.
Characteristics of the reviews and the primary studies that were included were independently assessed by 2 review
authors, using standardized forms.
Results: After consensus meetings a total of 50 systematic reviews that met the inclusion criteria were included. The
type of primary studies included (prognostic factor or outcome prediction) was unclear in two-thirds of the reviews. A
minority of the reviews reported univariable or multivariable point estimates and measures of dispersion from the
primary studies. Moreover, the variables considered for outcome prediction model development were often not
reported, or were unclear. In most reviews there was no information about model performance. Quantitative analysis
was performed in 10 reviews, and 49 reviews assessed the primary studies qualitatively. In both analyses types a range
of different methods was used to present the results of the outcome prediction studies.
Conclusions: Different methods are applied to synthesize primary study results but quantitative analysis is rarely
performed. The description of its objectives and of the primary studies is suboptimal and performance parameters of
the outcome prediction models are rarely mentioned. The poor reporting and the wide variety of data synthesis
strategies are prone to influence the conclusions of outcome prediction reviews. Therefore, there is much room for
improvement in reviews of outcome prediction studies.
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The methodology for prognosis research is still under
development. Although there is abundant literature to
help researchers perform this type of research [1-5],
there is still no widely agreed approach to building a
multivariable prediction model [6]. An important dis-
tinction in prognosis is made between prognostic factor
models, also called explanatory models and outcome* Correspondence: to.vandenberg@vumc.nl
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distribution, and reproduction in any mediumprediction models [7,8]. Prognostic factor studies investi-
gate causal relationships, or pathways between a single
(prognostic) factor and an outcome, and focus on the ef-
fect size (e.g. relative risk) of this prognostic factor
which ideally is adjusted for potential confounders. Out-
come prediction studies, on the other hand, combine
multiple factors (e.g. clinical and non-clinical patient
characteristics) in order to predict future events in indi-
viduals, and therefore focus on absolute risks, i.e. pre-
dicted probabilities in logistic regression analysis.
Methods that can be used to summarize data from prog-
nostic factor studies in a meta-analysis can easily beentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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outcome prediction studies. Therefore, in the present
study we focus on how authors of published reviews
have synthesized outcome prediction models. The no-
menclature to indicate various types of prognosis re-
search is not standardized. We use prognosis research as
an umbrella term for all research that might explain or
predict a future outcome and prognostic factor and out-
come prediction as specific types of prognosis studies.
In 2006, Hayden et al. showed that in systematic reviews
of prognosis studies, different methods are used to assess
the quality of primary studies [11]. Moreover, when quality
is assessed, integration of these quality scores in the syn-
thesis of the review is not guaranteed. For reviews of out-
come prediction models, additional characteristics are
important in the synthesis of models to reflect choices
made in the primary studies, such as which variables are
included in statistical models and how this selection was
made. These choices therefore also reflect the internal and
external validity of a model and influence the predictive
performance of the model. In systematic reviews the re-
searchers synthesize results across primary outcome pre-
diction studies which include different variables and show
methodological diversity. Moreover, relevant information is
not always available, due to poor reporting in the studies.
For example, several researchers have found that current
knowledge about the recommended number of events per
variable, and the coding and selection of variables, among
other features, are not always reported in primary outcome
prediction research [12-14]. Although improvement in pri-
mary studies themselves is needed, reviews that summarize
outcome prediction evidence need to consider the current
diversity in methodology in primary studies.
In this meta-review we focus on reviews of outcome
prediction studies, and how they summarize the cha-
racteristics of design and analysis, and the results of
primary studies. As there is no guideline nor agreement
how primary outcome prediction models in medical
research and epidemiology should be summarized in
systematic reviews, an overview of current methods helps
researchers to improve and develop these methods. More-
over, current methods for outcome prediction reviews are
unknown to the research community. Therefore, the aim
of this review was to provide an overview on how pub-
lished reviews of outcome prediction studies describe and
summarize the characteristics of the analyses in primary
studies, and how the data is synthesized.
Methods
Literature search and selection of studies
Systematic reviews and meta-analyses of outcome pre-
diction models that were published between October
2005 and March 2011 were searched. We were only
interested in reviews that included multivariableoutcome prediction studies. In collaboration with a med-
ical information specialist, we developed a search strat-
egy in MEDLINE, extending on the strategy used by
Hayden [11], by adding recommended other search
terms for predictive and prognostic research [15,16].
The full search strategy is presented in Appendix 1.
Based on title and abstract, potential eligible reviews
were selected by one author (TvdB), who in case of any
doubt included the review. Another author (MH)
checked the set of potential eligible reviews. Ineligible
reviews were excluded after consensus between both
authors. The full texts of the included reviews were read,
and if there was any doubt on eligibility a third review
author (HdV) was consulted. The inclusion criteria were
met if the study design was a systematic review with or
without a meta-analysis, multiple variables were studied
in an outcome prediction model, and the review was
written in the English language. Reviews were excluded
if they were based on individual patient data only, or
when the topic was genetic profiling.
Data-extraction
A data-extraction form was developed, based on impor-
tant items to prognosis [1,2,12,13,17], to assess the cha-
racteristics of reviews and primary studies and is
available from the first author on request. The items on
this data-extraction form are shown in Appendix 2. Be-
fore the form was finalized it was pilot-tested by all re-
view authors and minor adjustments were made after
discussion about the differences in scores. One review
author scored all reviews (TvdB) while other review au-
thors (MH, AV, DV, and SL) collectively scored all re-
views. Consensus meetings were held within 2 weeks
after a review had been scored to solve disagreements. If
consensus was not reached, a third reviewer (MH or
HdV) was consulted to make a final decision.
An item was scored ‘yes’ if positive information was
found about that specific methodological item, e.g. if it
was clear that sensitivity analyses were conducted. If it
was clear that a specific methodological requirement
was not fulfilled, a ‘no’ was scored, e.g. no sensitivity
analyses were conducted. In case of doubt or uncer-
tainty, ‘unclear’ was scored. Sometimes, a methodological
item could be scored as ‘not applicable’. The number of
reviews within a specific answer category was reported,
as well as the proportion.
Results
Literature search and selection process
The search strategy revealed 7889 references and, based
on title and abstract, 216 were selected to be read in full
text (see the flowchart in Figure 1). Of these reviews, 89
were excluded and 127 remained. Exclusions after the
full text had been read were mainly due to the focus of
Articles retrieved from 
search strategy (n=7889)
Exclusion based on title 
and abstract (n=7673)
Included articles
-outcome prediction 
(n=50)
Exclusion based on full text (n=89)
-prognostic factor studies (19)
-Individual patient data only (24)
-narrative review (10)
-not prognosis study (10)
-description of measurement- instrument/model 
(5)
-no disease outcome (4)
-studies on the course of disease (1)
-primary study (1)
-only genetic predictors (1)
-other (14)
Excluded reviews based on objective
-prognostic factor study (n=44)
-unclear objective (n=33)
Reviews for data 
extraction (n=127)
Reviews retrieved for 
full-text assessment 
(n=216)
Figure 1 Flowchart of the search and selection process.
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nostic factor study), analysis based on individual patient
data only, or a narrative overview study design. After
completing the data-extraction, the objectives and
methods of 44 reviews described summaries of prog-
nostic factor studies, and 33 reviews had an unclear
approach. Therefore, a total of 50 reviews on outcome
prediction studies were analyzed [18-67].
Data-extraction
After completing the data-extraction form for all of the in-
cluded reviews, most disagreements between review au-
thors were found on items concerning the review
objectives, the type of primary studies included, and the
method of qualitative data-synthesis. Unclear reporting and,
to a lesser degree, reading errors contributed to the dis-
agreements. After consensus meetings only a small propor-
tion of items needed to be discussed with a third reviewer.
Objective and design of the review
Table 1, section 1 shows the items with regard to infor-
mation about the reviews. Of the 50 reviews rated
as summaries of outcome prediction studies, less
than one third included only outcome prediction studies
*[23,27,28,32,35,39,44,48,50,52,55,58,60,66]. In about two
thirds, the type of primary studies that were includedwas unclear, and the remaining reviews included a com-
bination of prognostic factor and outcome prediction
studies. Most reviews clearly described their outcome of
interest. Also information about the assessment of the
methodological quality of the primary studies, i.e. risk of
bias, was provided in most reviews. In those that did,
two thirds described the basic design of the primary
studies in addition to a list of methodological criteria
(defined in our study as a list consisting of at least four
quality items). In some reviews an established criteria list
was used or adapted, or a new criteria list was
developed. In the reviews that assessed methodological
quality, less than half actually used this information to
account for differences in study quality, mainly by
performing a ‘levels of evidence’ analysis, subgroup-
analyses, or sensitivity analyses.Information about the design and results of the primary
studies
In Table 1, section 2 shows information provided about
the included primary studies. The outcome measures
used in the included studies were reported in most of
the reviews. Only 2 reviews [28,52] described the statis-
tical methods that were used in the primary studies to
select variables for inclusion of a final prediction model,
Table 1 Characteristics of the reviews and provided information about the included primary studies
n = 50 reviews
Item: Description of item: Yes No Unclear Not applicable
N % N % N % N %
Section 1: Information about the objective and design of the reviews
1. Type of primary studies included n = 50 (%)
Only outcome prediction models 14 (28.0)
Combination of prognostic factor & outcome prediction studies 3 (6.0)
Unclear 33 (66.0)
2. Is the outcome of interest clearly described? 47 (94.0) 1 (2.0) 2 (4.0)
3. Is information about quality assessment provided? 36 (72.0) 14 (28.0)
3a. Method used
Methodological criteria list 3 (6.0)
Individual items 2 (4.0)
Not applicable 14 (28.0)
Methodological criteria & study design 31 (62.0)
4. Was study quality accounted for 21 (42.0) 13 (26.0) 2 (4.0) 14 (28.0)
4a. Method used *# n = 23 (%)
Exclusion of poor quality studies (cut-off score used) 3 (13.0)
Sensitivity analysis based on total quality score 5 (21.7)
Levels of evidence 12 52.2)
Subgroup analysis 7 (30.4)
Study findings weighted for quality 3 (13.0)
Other 2 (8.7)
Section 2: Information about the design and results of the primary studies
5. Outcomes clearly described 36 (72.0) 20 (20.0) 4 (8.0)
6. Statistical methods used for variable selection described 2 (4.0) 46 (92.0) 2 (4.0)
7. Treatments described 6 (12.0) 37 (74.0) 7 (14.0)
8. Univariable point estimates for all the variables of the primary
studies are provided
5 (10.0) 42 (84.0) 3 (6.0)
8a. Univariable estimates for dispersion for all the variables of the primary
studies are provided
5 (10.0) 42 (84.0) 3 (6.0)
9. All variables (starting predictors) used to develop a model are described 4 (8.0) 36 (72.0) 10 (20.0)
10. Multivariable point estimates for each predictor in the final outcome
prediction model are provided
11 (22.0) 33 (66.0) 4 (8.0) 2 (4.0)
10a. Multivariable estimate of dispersion provided for each predictor in
the final outcome prediction model
11 (22.0) 33 (66.0) 4 (8.0) 2 (4.0)
11. Model performance is assessed and described 7 (14.0) 38 (76.0) 2 (4.0) 3 (6.0)
12. number of events per variable is described 4 (8.0) 44 (88.0) 2 (4.0)
Section 3: Data-analysis and synthesis in the reviews
13. Heterogeneity between studies described 45 (90.0) 4 (8.0) 1 (2.0)
14. Qualitative data-synthesis presented 49 (98.0) 1 (2.0)
14a. Method used n = 49 (%)
Statistical significance 22 (44.9)
Consistency of findings 7 (14.3)
Consistency of findings & statistical significance 6 (12.2)
Available method of defining levels of evidence 3 (6.1)
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Table 1 Characteristics of the reviews and provided information about the included primary studies (Continued)
Consistency of findings & levels of evidence 3 (6.1)
other combinations 8 (16.3)
15. Quantitative analysis performed 10 (20.0) 40 (80.0)
15a. Method used n = 10 (%)
Random effects model 4 (40.0)
Fixed effects model 1 (10.0)
Random & Fixed effects model 3 (30.0)
Other 2 (20.0)
n = 10 reviews
15b. Statistical heterogeneity assessed 4 (40.0) 6 (60.0)
15c. Method used to assess statistical heterogeneity n = 4 (%)
I2 2 (50.0)
I2 & Chi2 1 (25.0)
Other 1 (25.0)
n = 50 reviews
16. Graphic presentation of results provided 8 (16.0) 42 (84.0)
16a. Method used n = 8 (%)
Forest plot 6 (75.0)
Forest plot & scatter plot 1 (12.5)
Barplot 1 (12.5)
17. Sensitivity analysis performed 6 (12.0) 43 (86.0) 1 (2.0)
17a. Method used n = 6 (%)
Different cut-offs for study quality 3 (50.0)
Methodological criteria 1 (16.7)
Methodological criteria & weights for quality 1 (16.7)
Including other (excluded) cohorts 1 (16.7)
* includes ‘yes’ and ‘unclear’ categories.
# numbers and percentages may add up to more than 23 and 100%, due to multiple methods in some reviews.
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others whether and how patients were treated.
A minority of reviews [23,24,27,28] described for all
studies the variables that were considered for inclusion
in the outcome prediction model and only 5 reviews
[36,37,39,48,55] reported univariable point estimates
(i.e.. regression coefficients or odds ratios) and estimates
of dispersion (e.g. standard errors) of all studies. Simi-
larly, multivariable point estimates and estimates of
dispersion were reported in respectively 11 and 10 of the
reviews [21,26,27,31,33,37,44,52,55,64,65].
With regard to the presentation of univariable and
multivariable point estimates, 2 reviews presented both
types of results [37,55], 31 did not report any estimates,
and 17 reviews were unclear or reported only univariable
or multivariable results [not shown in the table]. Lastly,
model performance and number of events per variable
were reported in 7 reviews [32,39,41,60,61,65,66] and 4
reviews [40,48,58,61], respectively.Data-analysis and synthesis in the reviews
Table 1, section 3 illustrates how the results of primary
studies were summarized in the reviews. It shows that
heterogeneity was described in almost all reviews by
reporting differences in the study design and the charac-
teristics of the study population. All but one review [57]
summarized the results of included studies in a qualita-
tive manner. Methods that were mainly used for that
purpose were number of statistical significant results,
consistency of findings, or a combination of these. Quan-
titative analysis, i.e. statistical pooling, was performed in 10
of the 50 reviews [25,28,31,36,37,44,45,57-59]. The quanti-
tative methods used included random effects models and
fixed effects models of regression coefficients, odds ratios
or hazard ratios. Of these quantitative summaries, 40%
assessed the presence of statistical heterogeneity using I2,
Chi2, or the Q statistic. In two reviews [25,59], statistical
heterogeneity was found to be present, and subgroup
analysis was performed to determine the source of this
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there was a graphical presentation of the results, in which
a forest plot [25,28,36-38,52,59], per single predictor, was
the frequently used method. Other studies used a barplot
[57] or a scatterplot [38]. In 6 reviews [25,26,32,43,46,58]
a sensitivity analysis was performed to test the robustness
of the choices made such as changing the cut-off value for
a high or low quality primary study.
Discussion
We made an overview of how systematic reviews
summarize and report the results of primary outcome pre-
diction studies. Specifically, we extracted information on
how the data-synthesis was performed in reviews since
outcome prediction models may consider different poten-
tial predictors, and include a dissimilar set of variables in
the final prediction model, and use a variety of statistical
methods to obtain an outcome prediction model.
Currently, in prognosis studies a distinction is made
between outcome prediction models and prognostic
factor models. The methodology of data synthesis in a
review of the latter type of prognosis is comparable to
the methodology of aetiological reviews. For that reason,
in the present study we only focused on reviews of
outcome prediction studies. Nonetheless, we found it
difficult to distinct between both review types. Less than
half of the reviews that we initially selected for data-
extraction in fact seemed to serve an outcome prediction
purpose. It appeared that the other reviews summarized
prognostic factor studies only, or the objective was
unclear. In particular, prognostic factor reviews that
investigated more than one variable in addition to non-
specific objectives made it difficult to clarify what the
purpose of reviews was. As a consequence, we might
have misclassified some of the 44 excluded reviews rated
as prognostic factor. The objective of a review should
also include information about the type of study that is
included, that is of outcome prediction studies in this
case. However, we found that in reviews aimed at out-
come prediction the type of primary study was unclear
for two-thirds of the reviews. An example we encoun-
tered in a review was that their purpose was “to identify
preoperative predictive factors for acute post-operative
pain and analgesic consumption” although the review
authors included any study that identified one or more
potential risk factors or predictive factors. The risk of
combining both types of studies, i.e. risk factor or prog-
nostic factor studies and predictive factor studies, is that
inclusion of potential covariables in the former type are
based on change in regression coefficient of the risk fac-
tor while in the latter study type all potential predictor
variables are included based on their predictive ability of
the outcome. This distinction may lead to: 1) biased
results in a meta-analysis or other form of evidencesynthesis because a risk factor is not always predictive
for an outcome and 2) risk factor studies – if adjusted
for potential confounders at all – have a slightly different
method to obtain a multivariable model compared to
outcome prediction studies which may also lead to
biased regression coefficients. The distinction between
prognostic factor and outcome prediction studies was
already emphasized in 1983 by Copas [68]. He stated
that “a method for achieving a good predictor may be
quite inappropriate for other questions in regression
analysis such as the interpretation of individual regres-
sion coefficients”. In other words, the methodology of
outcome prediction modelling differs from that of prog-
nostic factor modelling, and therefore combining both
types of research into one review to reflect current
evidence should be discouraged. Hemingway et al. [2]
appealed for standard nomenclature in prognosis re-
search, and the results of our study underline their plea.
Authors of reviews and primary studies should clarify
their type of research, for example by using the terms
applied by Hayden et al. [8] ‘prognostic factor modelling’
and ‘outcome prediction modelling’, and give a clear
description of their objective.
Studies included in outcome prediction reviews are
rarely similar in design and methodology, and this is often
neglected when summarizing the evidence. Differences, for
instance in the variables studied and the method of analysis
for variable selection might explain heterogeneity in re-
sults, and should therefore be reported and reflected on
when striving to summarize evidence in the most appropri-
ate way. There is no doubt that the methodological quality
of primary studies included in reviews is related to the con-
cept of bias [69,70] and it is therefore important to assess
this [11,69,70]. Dissemination bias reflects if publication
bias is likely to be present, how this is handled and what is
done to correct for it [71]. To our knowledge, dissemin-
ation bias and especially its consequences in reviews of
outcome prediction models are not studied yet. Most likely
testimation bias [5], i.e. the predictors considered and the
amount of predictors in relation to the effective sample size
influence results more then publication bias. Therefore, we
did not study dissemination bias on the review level.
With regard to the reporting of primary study character-
istics in the systematic reviews, there is much room for
improvement. We found that the methods of model devel-
opment (e.g. the variables considered and the variable se-
lection methods used) in the primary studies were not, or
only vaguely reported in the included reviews. These
methods are however important, because variable selec-
tion procedures can affect the composition of the multi-
variable model due to estimation bias, or may result in an
increase in model uncertainty [72-74]. Furthermore, the
predictive performance of the model can be biased by
these methods [74]. We also found that only 5 of the
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received in the primary studies. Although prescribed treat-
ment is often not considered as a candidate predictor, it is
likely to have a considerable impact on prognosis. More-
over, treatment may vary in relation to predictive variables
[75], and although randomized controlled trials provide
patients with similar treatment strategies, in cohort stu-
dies which are most often seen in prognosis research this
is often not the case. Regardless of difficulties in defining
groups that receive the same treatment, it is imperative to
consider treatment in outcome prediction models. In
order to ensure correct data-synthesis of the results, the
primary studies not only should provide point estimates
and estimates of dispersion of all the included variables,
but also for non-significant findings. Whereas the results
of positive or favourable findings are more often reported
[75-78], the effects of predictive factors that do not reach
statistical significance also need to be compared and sum-
marized in a review. Imagine a variable being of statistical
significance in one article, but not reported in others be-
cause of non-significance. It is likely that this one signifi-
cant result is a spurious finding or that the others were
underpowered. Without information about the non-
significant findings in other studies, biased or even
incorrect conclusions might be drawn. This means that
reporting of the evidence of primary studies should be ac-
companied by the results of univariable and multivariable
associations, regardless of their level of significance. More-
over, confidence intervals, or other estimates of dispersion
are also needed in the review, and unfortunately these
results were not presented in most of the reviews in our
study. Some reviews considered differences in unadjusted
and adjusted results, and the results of one review were
sensibly stratified according to univariable and multivari-
able effects [38]. Other reviews merely reported mul-
tivariable results [31], or only univariable results if
multivariable results were unavailable [58]. In addition to
the multivariable results of a final prediction model, the
predictive performance of these models is important for
the assessment of clinical usefulness [79]. A prediction
model in itself does not indicate how much variance in
outcome is explained by the included variables. Unfortu-
nately, in addition to the non-reporting of several primary
study characteristics, the performance of the models was
rarely reported in the reviews included in our overview.
Different stages can be distinguished in outcome pre-
diction research [80]. Most outcome prediction models
evaluated in the systematic reviews appeared to be in a
developmental phase. Before implementation in daily
practice, confirmation of the results in other studies is
needed. With this type of validation studies underway,
in future reviews we should acknowledge the difference
between externally validated models and models from
developmental studies, and analyze them separately.In systematic reviews data can be combined quantita-
tively, i.e. a meta-analysis can be performed. This was
done in 10 of the reviews. All of them combined point
estimates (mostly odds ratios, but also a mix of odds
ratios, hazard ratios and relative risks) and confidence
intervals for single outcome prediction variables. This
made it possible to calculate a pooled point estimate,
often complemented with confidence intervals [81].
However, in outcome prediction research we are inter-
ested in the estimates of a combination of predictive fac-
tors, which makes it possible to calculate absolute risks
or probabilities to predict an outcome in individuals
[82]. Even if the relative risk of a variable is statistically
significant, it does not provide information about the
extent to which this variable is predictive for a particular
outcome. The distribution of predictor values, outcome
prevalence, and correlations between variables also influ-
ences the predictive value of variables within a model
[83]. Effect sizes also provide no information about the
amount of variation in outcomes that is explained. In
summary: the current quantitative methods seem to be
more of an explanatory way of summarizing the available
evidence, instead of quantitatively summarizing com-
plete outcome prediction models.
Medline was the only database that was searched for
relevant reviews. Our intention was to provide an overview
of recently published reviews and not to include all rele-
vant outcome prediction reviews. Within Medline, some
eligible reviews may have been missed if their titles and ab-
stracts did not include relevant terms and information. An
extensive search strategy was applied and abstracts were
screened thoroughly and discussed in case of disagreement.
Data-extraction was performed in pairs to prevent reading
and interpretation errors. Disagreements mainly occurred
when deciding on the objective of a review and the type of
primary studies included, due to poor reporting in most of
the reviews. This indicates a lack of clarity, explanation and
reporting within reviews. Therefore, screening in pairs is a
necessity, and standardized criteria should be developed
and applied in future studies focusing on such reviews.
Consistency in rating on the data-extraction form was en-
hanced by one review author rating all reviews, with one of
the other review authors as second rater. Several items
were scored as “no”, but we did not know whether this was
a true negative (i.e. leading to bias) or that no information
was reported about a particular item. For review authors it
is especially difficult to summarize information about pri-
mary studies because there may be a lack of information in
the studies [13,14,84].
Implications
There is still no available methodological procedure for
a meta-analysis of regression coefficients of multivariable
outcome prediction models. Some authors, such as Riley
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remains practically impossible, due to poor reporting,
publication bias, and heterogeneity across studies. How-
ever, a considerable number of outcome prediction studies
have been published, and it would be useful to integrate
this body of evidence into one summary result. Moreover,
there is an increase in the number of reviews that are
being published. Therefore, there is a need to find the best
strategy to integrate the results of primary outcome
prediction studies. Consequently, until a method to quan-
titatively synthesize results has been developed, a sensible
qualitative data-synthesis, which takes methodological
differences between primary studies into account, is indi-
cated. In summarizing the evidence, differences in meth-
odological items and model-building strategies should be
described and taken into account when assessing the over-
all evidence for outcome prediction. For example, uni-
variable and multivariable results should be described
separately, or subgroup analyses should be performed
when they are combined. Other items that, in our opinion
should be taken into consideration with regard to the
data-synthesis are: study quality, variables used for model
development, statistical methods used for variable selec-
tion procedures, the performance of models, and sufficient
cases and non-cases to guarantee adequate study power.
Regardless of whether or not these items are taken into
consideration in the data-synthesis, we strongly recom-
mend that in reviews they are described for all primary
studies included so that readers can also take them into
consideration.
Conclusion
In conclusion, poor reporting of relevant information
and differences in methodology occur in primary out-
come prediction research. Even the predictive ability of
the models was rarely reported. This, together with our
current inability to pool multivariable outcome predic-
tion models, challenges review authors to make informa-
tive reviews of outcome prediction models.
Appendix 1
Search strategy: 01-03-2011
Database: MEDLINE
((“systematic review”[tiab] OR “systematic reviews”[tiab]
OR “Meta-Analysis as Topic”[Mesh] OR meta-analysis
[tiab] OR “Meta-Analysis”[Publication Type]) AND (“2005/
11/01”[EDat] : “3000”[EDat]) AND ((“Incidence”[Mesh] OR
“Models, Statistical”[Mesh] OR “Mortality”[Mesh] OR
“mortality ”[Subheading] OR “Follow-Up Studies”[Mesh]
OR “Prognosis”[Mesh:noexp] OR “Disease-Free Survi-
val”[Mesh] OR “Disease Progression”[Mesh:noexp] OR
“Natural History”[Mesh] OR “Prospective Studies”[Mesh])
OR ((cohort*[tw] OR course*[tw] OR first episode*[tw] OR
predict*[tw] OR predictor*[tw] OR prognos*[tw] ORfollow-up stud*[tw] OR inciden*[tw]) NOT medline[sb])))
NOT ((“addresses”[Publication Type] OR “biogra-
phy”[Publication Type] OR “case reports”[Publication
Type] OR “comment”[Publication Type] OR “directo-
ry”[Publication Type] OR “editorial”[Publication Type] OR
“festschrift”[Publication Type] OR “interview”[Publication
Type] OR “lectures”[Publication Type] OR “legal ca-
ses”[Publication Type] OR “legislation”[Publication Type]
OR “letter”[Publication Type] OR “news”[Publication Type]
OR “newspaper article”[Publication Type] OR “patient
education handout”[Publication Type] OR “popular
works”[Publication Type] OR “congresses”[Publication
Type] OR “consensus development conference”[Pub-
lication Type] OR “consensus development conference,
nih”[Publication Type] OR “practice guideline”[Publi-
cation Type]) OR (“Animals”[Mesh] NOT (“Animals”[Mesh]
AND “Humans”[Mesh]))).
Appendix 2
Items used to assess the characteristics of analyses in
outcome prediction primary studies and reviews:
Information about the review:
1. What type of studies are included?
2. Is(/are) the outcome(s) of interest clearly described?
3. Is information about the quality assessment method
provided?
a. What method was used?
4. Did the review account for quality?
a. What method was used?
Information about the analysis of the primary studies:
5. Are the outcome measures clearly described?
6. Is the statistical method used for variable selection
described?
7. Is there a description of treatments received provided?
Information about the results of the primary studies:
8. Are crude univariable associations and estimates of
dispersion for all the variables of the primary studies
presented?
9. Are all variables that were used for model development
described?
10. Are the multivariable associations and estimates of
dispersions presented?
11. Is model performance assessed and reported?
12. Is the number of predictors relative to the number of
outcome events described?
Data-analysis and synthesis of the review:
13. Is the heterogeneity of primary studies described?
14. Is a qualitative synthesis presented?
a. What method was used?
15. Are methods for quantitative analysis described?
a. What method was used?
b. Is the statistical heterogeneity assessed?
c. What method is used to assess statistical heterogen-
eity?
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http://www.biomedcentral.com/1471-2288/13/42d. If statistical heterogeneity exists, are sources of the
heterogeneity investigated?
e. What method is used to investigate potential sources
of heterogeneity?
16. Is a graphical presentation of the results provided?
a. What method was used?
17. Are sensitivity analysis performed?
a. On which level?
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